These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
120 related articles for article (PubMed ID: 8903330)
21. A chimeric humanized single-chain antibody against the type I insulin-like growth factor (IGF) receptor renders breast cancer cells refractory to the mitogenic effects of IGF-I. Sachdev D; Li SL; Hartell JS; Fujita-Yamaguchi Y; Miller JS; Yee D Cancer Res; 2003 Feb; 63(3):627-35. PubMed ID: 12566306 [TBL] [Abstract][Full Text] [Related]
22. Activation of the insulin-like growth factor 1 signaling pathway by the antiapoptotic agents aurintricarboxylic acid and evans blue. Beery R; Haimsohn M; Wertheim N; Hemi R; Nir U; Karasik A; Kanety H; Geier A Endocrinology; 2001 Jul; 142(7):3098-107. PubMed ID: 11416032 [TBL] [Abstract][Full Text] [Related]
23. IGF-I receptor protection from apoptosis in cells lacking the IRS proteins. Dews M; Nishimoto I; Baserga R Recept Signal Transduct; 1997; 7(4):231-40. PubMed ID: 9633824 [TBL] [Abstract][Full Text] [Related]
24. Protein kinase C modulation of insulin receptor substrate-1 tyrosine phosphorylation requires serine 612. De Fea K; Roth RA Biochemistry; 1997 Oct; 36(42):12939-47. PubMed ID: 9335553 [TBL] [Abstract][Full Text] [Related]
25. Structural and functional characterization of insulin receptor substrate proteins and the molecular mechanisms of their interaction with insulin superfamily tyrosine kinase receptors and effector proteins. Shpakov AO; Pertseva MN Membr Cell Biol; 2000; 13(4):455-84. PubMed ID: 10926366 [TBL] [Abstract][Full Text] [Related]
26. Identification of structural characteristics that contribute to a difference in antiapoptotic function between human insulin and insulin-like growth factor 1 receptors. Chen H; Yan GC; Gishizky ML Cell Growth Differ; 1998 Nov; 9(11):939-47. PubMed ID: 9831246 [TBL] [Abstract][Full Text] [Related]
27. Activation of the insulin-like growth factor type 1 receptor by deletion of amino acids 870-905. Li S; Zhang H; Hoff H; Sell C Exp Cell Res; 1998 Sep; 243(2):326-33. PubMed ID: 9743592 [TBL] [Abstract][Full Text] [Related]
28. Regulation of breast cancer cell motility by insulin receptor substrate-2 (IRS-2) in metastatic variants of human breast cancer cell lines. Jackson JG; Zhang X; Yoneda T; Yee D Oncogene; 2001 Nov; 20(50):7318-25. PubMed ID: 11704861 [TBL] [Abstract][Full Text] [Related]
29. Crk protein binds to PDGF receptor and insulin receptor substrate-1 with different modulating effects on PDGF- and insulin-dependent signaling pathways. Sorokin A; Reed E; Nnkemere N; Dulin NO; Schlessinger J Oncogene; 1998 May; 16(19):2425-34. PubMed ID: 9627109 [TBL] [Abstract][Full Text] [Related]
30. Insulin receptor substrate-1 pleckstrin homology and phosphotyrosine-binding domains are both involved in plasma membrane targeting. Jacobs AR; LeRoith D; Taylor SI J Biol Chem; 2001 Nov; 276(44):40795-802. PubMed ID: 11526109 [TBL] [Abstract][Full Text] [Related]
31. Overexpression of insulin receptor substrate-2 in human and murine hepatocellular carcinoma. Boissan M; Beurel E; Wendum D; Rey C; Lécluse Y; Housset C; Lacombe ML; Desbois-Mouthon C Am J Pathol; 2005 Sep; 167(3):869-77. PubMed ID: 16127164 [TBL] [Abstract][Full Text] [Related]
32. Structural and biochemical characterization of the KRLB region in insulin receptor substrate-2. Wu J; Tseng YD; Xu CF; Neubert TA; White MF; Hubbard SR Nat Struct Mol Biol; 2008 Mar; 15(3):251-8. PubMed ID: 18278056 [TBL] [Abstract][Full Text] [Related]
33. Increased activity and expression of MAP kinase in HCC model rats induced by 3'-methyl-4-dimethylamino-azobenzene. Toyoda M; Hashimoto N; Tokita K; Goldstein BJ; Yokosuka O; Kanatsuka A; Suzuki Y; Saito Y J Hepatol; 1999 Oct; 31(4):725-33. PubMed ID: 10551398 [TBL] [Abstract][Full Text] [Related]
34. Transgenic overexpression of insulin receptor substrate 1 in hepatocytes enhances hepatocellular proliferation in young mice only. Mohr L; Banerjee K; Kleinschmidt M; Bartolomé Rodríguez MM; Wands JR Hepatol Res; 2008 Dec; 38(12):1233-40. PubMed ID: 18631251 [TBL] [Abstract][Full Text] [Related]
35. Expression of insulin receptor substrate-1 in hepatocytes: an investigation using monoclonal antibodies. Furusaka A; Nishiyama M; Ohkawa K; Yamori T; Tsuruo T; Yonezawa K; Kasuga M; Hayashi S; Tanaka T Cancer Lett; 1994 Aug; 84(1):85-92. PubMed ID: 8076365 [TBL] [Abstract][Full Text] [Related]
36. More meanders and sandwiches. Riddihough G Nat Struct Biol; 1994 Nov; 1(11):755-7. PubMed ID: 7634082 [No Abstract] [Full Text] [Related]
37. Insulin-Like Growth Factor 1 Receptor-Dependent Pathway Drives Epicardial Adipose Tissue Formation After Myocardial Injury. Zangi L; Oliveira MS; Ye LY; Ma Q; Sultana N; Hadas Y; Chepurko E; Später D; Zhou B; Chew WL; Ebina W; Abrial M; Wang QD; Pu WT; Chien KR Circulation; 2017 Jan; 135(1):59-72. PubMed ID: 27803039 [TBL] [Abstract][Full Text] [Related]
38. An insulin signaling feedback loop regulates pancreas progenitor cell differentiation during islet development and regeneration. Ye L; Robertson MA; Mastracci TL; Anderson RM Dev Biol; 2016 Jan; 409(2):354-69. PubMed ID: 26658317 [TBL] [Abstract][Full Text] [Related]
39. Activation of signal transduction pathways during hepatic oncogenesis. Chung W; Kim M; de la Monte S; Longato L; Carlson R; Slagle BL; Dong X; Wands JR Cancer Lett; 2016 Jan; 370(1):1-9. PubMed ID: 26433160 [TBL] [Abstract][Full Text] [Related]